OPPORTUNITIES FOR EARLIER ACCESS TO NEW MEDICINES
November 2023Philip Delistoyanov and Bill Dempster | Provincial Reimbursement Advisor
2023
PHARMAFOCUS 2027 UPDATE
November 2023Gerry Jeffcott, Bill Dempster, Don Sancton, Michel Parent, Stephanie Levee | IQVIA
UNDER THE MICROSCOPE: EXAMINING MEDICATION SPENDING GROWTH ACROSS CANADA
August 2023Gerry Jeffcott | Provincial Reimbursement Advisor
PHARMAFOCUS 2027
June 2023Gerry Jeffcott, Bill Dempster, Don Sancton, Michel Parent, Jodie Kiss, Stephanie Levee | IQVIA
HOW FOUR KEY EVENTS OF 2022 WILL IMPACT THE PHARMACEUTICAL ENVIRONMENT IN 2023
February 2023Don Sancton (with insights from Fred Horne) | Provincial Reimbursement Advisor
PROFILES IN REIMBURSEMENT – CONTRIBUTIONS MADE BY THE CANADIAN INSTITUTE FOR HEALTH INFORMATION
May 2023Gerry Jeffcott | Provincial Reimbursement Advisor
HOW WILL NEW DRUGS FOR OBESITY AND ALZHEIMER’S DISEASE BE RECEIVED BY CANADIAN PUBLIC PAYERS?
May 2023Don Sancton | Provincial Reimbursement Advisor